Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - BARRETT RONALD W
Last Updated 
6-Jul-16
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

BARRETT RONALD W: Declared Holdings
Company/RelationshipReportedShares  Ownership
Concert Pharmaceuticals, Inc.
Director
NasdaqGM:CNCE
(historical quotes, profile, other insiders)
9-Nov-150  Direct
XenoPort, Inc.
Officer
NasdaqGS:XNPT
(historical quotes, profile, other insiders)
1-Sep-15191,703  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
9-Nov-15 17,699CNCE Option Exercise at $1.13 - $1.13 per share.
(Cost of about $20,000)
9-Nov-15 17,699CNCE Sale at $21.90 - $22.75 per share.
(Proceeds of about $395,000)
1-Sep-15 12,500XNPT Automatic Sale at $7 - $7 per share.
(Proceeds of about $88,000)
15-Jul-15 12,500XNPT Automatic Sale at $7.20 - $7.2 per share.
(Proceeds of about $90,000)
13-Jul-15 12,500XNPT Automatic Sale at $7 - $7 per share.
(Proceeds of about $88,000)
14-Jan-15 4,697XNPT Disposition (Non Open Market) at $9.31 - $9.31 per share.
(Value of about $44,000)
14-Jan-15 12,500XNPT Option Exercise at $0 per share.
13-Jan-15 20,161XNPT Disposition (Non Open Market) at $8.93 - $8.93 per share.
(Value of about $180,000)
13-Jan-15 53,750XNPT Option Exercise at $0 per share.
2-Jan-15 66,666XNPT Option Exercise at $6 - $6 per share.
(Cost of about $400,000)
2-Jan-15 45,298XNPT Disposition (Non Open Market) at $8.83 - $8.83 per share.
(Value of about $400,000)
8-Dec-14 7,015XNPT Sale at $8.30 - $8.4 per share.
(Proceeds of about $59,000)


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?